抽象的な
Scientific progresses and hones of chemotherapy resistance and drug technology in tongue cancers.
Thomas Mulder*
The primary target of metronomic chemotherapy was originally identified as endothelial cells supporting the tumour vasculature, and not the tumour cells themselves, consistent with the emerging concept of cancer as a systemic disease involving both tumour cells and their microenvironment. While anti-angiogenesis is an important mechanism of action of metronomic chemotherapy, other mechanisms, including activation of anti-tumour immunity and a decrease in acquired therapeutic resistance, have also been identified.
免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。